secwatch / observer
8-K/A filed October 30, 2023, 7:59 PM ET ticker BGLC CIK 0001737523
leadership confidence high sentiment neutral materiality 0.30

BioNexus Gene Lab amends 8-K to disclose CEO and CFO are father and daughter

BioNexus Gene Lab Corp

BioNexus Gene Lab Corp filing history →

Source: SEC EDGAR
accession 0001477932-23-007962
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.